Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis.
Liver cirrhosis represents the common end-stage of chronic liver diseases regardless of its etiology. Patients with compensated disease are mostly asymptomatic, however, progression to a decompensated disease stage is common. The available stratification strategies are often unsuitable to identify p...
Main Authors: | Fabian Benz, Andreas Bogen, Michael Praktiknjo, Christian Jansen, Carsten Meyer, Alexander Wree, Muenevver Demir, Sven Loosen, Mihael Vucur, Robert Schierwagen, Frank Tacke, Jonel Trebicka, Christoph Roderburg |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0231701 |
Similar Items
-
Soluble urokinase plasminogen activator receptor levels predict survival in patients with portal hypertension undergoing TIPS
by: Sven H. Loosen, et al.
Published: (2024-05-01) -
Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis.
by: Alexander Queck, et al.
Published: (2019-01-01) -
Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
by: Tilman Sauerbruch, et al.
Published: (2023-01-01) -
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapyKey points
by: Yasuko Iwakiri, et al.
Published: (2021-08-01) -
Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments
by: Chandana B. Herath, et al.
Published: (2022-03-01)